Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-07

Clinical Trial Update: Alcohol Biosensor Monitoring for Alcoholic Liver Disease [NA]

View source ↗

Summary

A completed clinical trial evaluating alcohol biosensor monitoring for alcoholic liver disease with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pittsburgh | Conditions: Alcohol Use, Unspecified | NA | Status: COMPLETED | Results posted: 2022-11-07